The Impact of Disease Duration on Microcirculatory Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes

Jolanta Neubauer-Geryk1, Melanie Wielicka1, Magdalena Hoffmann2

  • 1Clinical Physiology Unit, Medical Simulation Centre, Medical University of Gdańsk, 80-210 Gdańsk, Poland.

Biomedicines
|May 25, 2024
PubMed

Insights

Early microcirculation changes in type 1 diabetes mellitus (T1D) are subtle. In long-standing T1D, capillary function correlates with oxygen pressure, but early T1D requires multiple tests for accurate microcirculation assessment.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Cardiovascular Research

Background:

  • Type 1 diabetes mellitus (T1D) can affect microcirculation early.
  • Assessing microvascular changes in pediatric T1D is crucial for understanding disease progression.

Purpose of the Study:

  • To evaluate early structural and functional microcirculatory changes in children and adolescents with T1D.
  • To investigate the impact of diabetes duration on microcirculation using capillaroscopy and transcutaneous oxygen pressure.

Main Methods:

  • Capillaroscopy and transcutaneous oxygen pressure (TcPO2) measurements were performed at baseline and during post-occlusive reactive hyperemia (PORH).
  • Sixty-seven pediatric T1D patients and 28 healthy controls were analyzed.
  • Diabetic patients were subgrouped by disease duration.

Main Results:

  • No significant differences in microcirculation parameters were found between T1D subgroups at rest or after PORH.
  • In long-standing T1D, negative correlations were observed between capillary coverage post-PORH and TcPO2 at biological zero.
  • Positive correlations were found between capillary distance post-PORH and TcPO2 at biological zero.

Conclusions:

  • Early T1D microcirculation dysfunction may not manifest simultaneously across all tested parameters.
  • Utilizing multiple diagnostic tests offers a more comprehensive characterization of microcirculation in shorter-duration T1D.
  • Longer diabetes duration shows correlations between microvascular function and oxygenation levels.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
524
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
921
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
265